219 related articles for article (PubMed ID: 9583194)
1. Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.
Ichida F; Uese K; Hamamichi Y; Hashimoto I; Tsubata S; Fukahara K; Murakami A; Miyawaki T
Acta Paediatr Jpn; 1998 Feb; 40(1):14-9. PubMed ID: 9583194
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
Adatia I; Barrow SE; Stratton P; Ritter JM; Haworth SG
Br Heart J; 1993 Feb; 69(2):179-82. PubMed ID: 8435245
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
Adatia I; Barrow SE; Stratton PD; Miall-Allen VM; Ritter JM; Haworth SG
Circulation; 1993 Nov; 88(5 Pt 1):2117-22. PubMed ID: 8222105
[TBL] [Abstract][Full Text] [Related]
4. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Christman BW; McPherson CD; Newman JH; King GA; Bernard GR; Groves BM; Loyd JE
N Engl J Med; 1992 Jul; 327(2):70-5. PubMed ID: 1603138
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
6. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin.
Fukushima H; Kosaki K; Sato R; Yagihashi T; Gatayama R; Kodo K; Hayashi T; Nakazawa M; Tsuchihashi T; Maeda J; Kojima Y; Yamagishi H; Takahashi T
Am J Med Genet A; 2010 Aug; 152A(8):1919-24. PubMed ID: 20583254
[TBL] [Abstract][Full Text] [Related]
8. Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension.
Kühl PG; Cotton RB; Schweer H; Seyberth HW
Arch Dis Child; 1989 Jul; 64(7 Spec No):949-52. PubMed ID: 2673060
[TBL] [Abstract][Full Text] [Related]
9. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
Lin JS; Lui SM; Chen CM; Chang WC
J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
[TBL] [Abstract][Full Text] [Related]
10. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
11. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants.
Ylikorkala O; Pekonen F; Viinikka L
J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid 6-keto-prostaglandin F1 alpha and thromboxane B2 during labor.
Mäkäräinen L; Ylikorkala O
Am J Obstet Gynecol; 1984 Nov; 150(6):765-8. PubMed ID: 6388335
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
Kurki T; Viinikka L; Ylikorkala O
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
[TBL] [Abstract][Full Text] [Related]
14. Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs.
Hales CA; Sonne L; Peterson M; Kong D; Miller M; Watkins WD
J Clin Invest; 1981 Aug; 68(2):497-505. PubMed ID: 7021593
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt.
Adatia I; Barrow SE; Stratton PD; Ritter JM; Haworth SG
Br Heart J; 1994 Nov; 72(5):452-6. PubMed ID: 7818962
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study.
Paarlberg KM; de Jong CL; van Geijn HP; van Kamp GJ; Heinen AG; Dekker GA
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1559-64. PubMed ID: 9855596
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurements of prostacyclin and thromboxane metabolites during the menstrual cycle.
Presser SC; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1991 Sep; 165(3):647-51. PubMed ID: 1892191
[TBL] [Abstract][Full Text] [Related]
19. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
Moutquin JM; Lindsay C; Arial N; De Grandpré P; C-Gaudreault R; Forest JC; Massé J
Am J Obstet Gynecol; 1997 Dec; 177(6):1483-90. PubMed ID: 9423755
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
Mizugaki M; Hishinuma T; Matsumura E; Murai Y; Yamazaki T; Yamanobe S; Tamai M
Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):253-62. PubMed ID: 10593167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
